Research interests include sedation, renal replacement therapy, nutrition, echocardiography and ultrasound, extracorporeal techniques, mechanical ventilation and sepsis. The department is a member of the ANZICS Clinical Trials Group (CTG) and has collaborated on numerous multi-centre trials. Collaboration with industry has evaluated methods of oxygen delivery that has been published and presented. The Department has published in excess of 100 peer reviewed publications and presented extensively both locally and internationally over the last decade.
Research Goal: To undertake sustainable and translational research that delivers evidence-based care of the critically ill.
- Effect of Dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomised clinical trial.
- Early experience of a novel extracorporeal carbon dioxide removal device in management of acute hypercapnic respiratory failure
- Intravenous amino acid therapy for kidney function in critically ill patients: a randomised controlled trial. Intensive Care Medicine
- Intensive care discharge delay is associated with increased hospital length of stay: a multicentre prospective observational study
- Effects of hypercapnia and hypercapnic acidosis on hospital mortality in mechanically ventilated patients
Professor John Botha
Has been site investigator of numerous CTG trials and was on the Management Committee of the NHMRC funded Nephroprotect Trial.View Monash Pure profile
Professor Ravindranath Tiruvoipati
Is investigating the role of C02 in mechanically ventilated patients. He has extensive experience in ECMO and was a lead investigator in the CESAR study published in the Lancet.View Monash Pure profile
Is conducting a PhD on the role of bedside echocardiography and ultrasound on management of the critically ill.View Monash Pure profile
Associate Professor Ian CarneyView Monash Pure profile
Sachin GuptaView Monash Pure profile